ChemPartner PharmaTech Co.,Ltd. (SHE:300149)
China
· Delayed Price · Currency is CNY 10.00
-0.60 (-5.66%)
At close: Apr 29, 2026
ChemPartner PharmaTech Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 4,980 | 4,761 | 3,185 | 3,809 | 5,184 | 6,882 | Upgrade
|
| Market Cap Growth | 45.46% | 49.45% | -16.38% | -26.51% | -24.68% | -6.52% | Upgrade
|
| Enterprise Value | 5,016 | 4,847 | 3,370 | 4,185 | 5,574 | 8,390 | Upgrade
|
| Last Close Price | 10.00 | 9.56 | 6.42 | 7.65 | 10.41 | 13.81 | Upgrade
|
| PE Ratio | 371.28 | 354.94 | - | - | 13.69 | - | Upgrade
|
| Forward PE | - | 50.40 | 50.40 | 50.40 | 50.40 | 50.40 | Upgrade
|
| PS Ratio | 4.39 | 4.20 | 3.28 | 3.35 | 3.91 | 4.07 | Upgrade
|
| PB Ratio | 3.83 | 3.66 | 2.57 | 2.61 | 2.17 | 3.46 | Upgrade
|
| P/TBV Ratio | 4.01 | 3.83 | 2.69 | 3.01 | 3.58 | 11.31 | Upgrade
|
| P/FCF Ratio | 38.89 | 37.18 | 32.19 | - | - | 74.63 | Upgrade
|
| P/OCF Ratio | 26.14 | 24.99 | 18.94 | 25.23 | 19.75 | 18.20 | Upgrade
|
| EV/Sales Ratio | 4.42 | 4.27 | 3.47 | 3.68 | 4.20 | 4.96 | Upgrade
|
| EV/EBITDA Ratio | 47.40 | 53.19 | - | - | 380.03 | 47.41 | Upgrade
|
| EV/EBIT Ratio | 128.28 | 123.98 | - | - | - | 128.47 | Upgrade
|
| EV/FCF Ratio | 39.18 | 37.86 | 34.06 | - | - | 90.98 | Upgrade
|
| Debt / Equity Ratio | 0.36 | 0.36 | 0.42 | 0.44 | 0.41 | 0.88 | Upgrade
|
| Debt / EBITDA Ratio | 4.43 | 4.43 | 15.63 | 8.58 | 9.94 | 6.73 | Upgrade
|
| Debt / FCF Ratio | 3.67 | 3.67 | 5.19 | - | - | 18.94 | Upgrade
|
| Net Debt / Equity Ratio | 0.01 | 0.01 | 0.12 | 0.20 | 0.09 | 0.79 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.13 | 0.13 | -3.65 | -115.47 | 13.95 | 8.86 | Upgrade
|
| Net Debt / FCF Ratio | 0.09 | 0.09 | 1.45 | -5.68 | -2.77 | 17.00 | Upgrade
|
| Asset Turnover | 0.56 | 0.56 | 0.44 | 0.36 | 0.33 | 0.41 | Upgrade
|
| Inventory Turnover | 77.47 | 77.47 | 39.07 | 24.31 | 17.91 | 18.74 | Upgrade
|
| Quick Ratio | 1.98 | 1.98 | 1.67 | 1.48 | 1.64 | 0.56 | Upgrade
|
| Current Ratio | 2.15 | 2.15 | 1.86 | 1.70 | 1.75 | 0.69 | Upgrade
|
| Return on Equity (ROE) | 1.07% | 1.07% | -16.79% | -47.67% | 17.30% | -18.11% | Upgrade
|
| Return on Assets (ROA) | 1.21% | 1.21% | -2.74% | -1.31% | -1.49% | 0.98% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.50% | 2.46% | -6.22% | -3.02% | -1.58% | 1.90% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.30% | 2.30% | -5.90% | -3.30% | -3.10% | 2.00% | Upgrade
|
| Earnings Yield | 0.27% | 0.28% | -7.11% | -24.07% | 7.30% | -5.85% | Upgrade
|
| FCF Yield | 2.57% | 2.69% | 3.11% | -1.32% | -1.42% | 1.34% | Upgrade
|
| Payout Ratio | 21.63% | 21.63% | - | - | 9.88% | - | Upgrade
|
| Buyback Yield / Dilution | 11.17% | 11.17% | -1.01% | -0.02% | -0.31% | 0.64% | Upgrade
|
| Total Shareholder Return | 11.17% | 11.17% | -1.01% | -0.02% | -0.31% | 0.64% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.